Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). ICU Medical's share price for the quarter that ended in Mar. 2025 was $138.86. ICU Medical's Shares Outstanding (EOP) for the quarter that ended in Mar. 2025 was 25 Mil. Therefore, ICU Medical's market cap for the quarter that ended in Mar. 2025 was $3,417 Mil.
ICU Medical's quarterly market cap
declined
from Sep. 2024 ($4,457 Mil) to Dec. 2024 ($3,804 Mil) and
declined
from Dec. 2024 ($3,804 Mil) to Mar. 2025 ($3,417 Mil).
ICU Medical's annual market cap
declined
from Dec. 2022 ($3,778 Mil) to Dec. 2023 ($2,408 Mil) but then
increased
from Dec. 2023 ($2,408 Mil) to Dec. 2024 ($3,804 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. ICU Medical's Enterprise Value for Today is $4,561 Mil.
ICU Medical Market Cap Historical Data
The historical data trend for ICU Medical's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of ICU Medical's Market Cap
For the Medical Instruments & Supplies subindustry, ICU Medical's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
ICU Medical's Market Cap Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, ICU Medical's Market Cap distribution charts can be found below:
* The bar in red indicates where ICU Medical's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
ICU Medical's Market Cap for the fiscal year that ended in Dec. 2024 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ICU Medical (NAS:ICUI) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
ICU Medical Market Cap Related Terms
Thank you for viewing the detailed overview of ICU Medical's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (43% of consolidated revenue), infusion systems (28%), and vital care (29%). The combined entity remains primarily US-focused, generating over 63% of its sales domestically.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ICUI has been successfully added to your 